Showing results (1191-1200 of 1,708) with videos related to
Sort By:
Pageof 171
Journal of the American College of Cardiology|March 23, 2019
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-ITDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.Hypertension (Dallas, Tex. : 1979)|October 4, 2021
Serum Potassium and Mortality in High-Risk Patients: SPRINTChristina Byrne, Manan Pareek, Muthiah Vaduganathan, et al.Critical Pathways in Cardiology|August 31, 2010
Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosisWilliam E Boden, Gregory S Cherr, Kim A Eagle, et al.Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.Journal of the American College of Cardiology|January 14, 2017
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary InterventionMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2019
Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-AnalysisThomas A Mavrakanas, Yiannis S Chatzizisis, Karim Gariani, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 9, 2017
Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.Circulation. Cardiovascular Interventions|April 11, 2018
Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Elliott M Groves, Deepak L Bhatt, Philippe Gabriel Steg, et al.Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.Pageof 171